6.51
price up icon1.79%   0.10
after-market Dopo l'orario di chiusura: 6.52 0.010 +0.15%
loading

Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 80.00
Operating Expenses
2.88%
19.82
20.40 19.43 25.13 27.51
Operating Income/Loss
2.88%
-19.82
-20.40 -19.43 -25.13 52.49
Income/Loss From Continuing Operations Before Tax
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Income/Loss From Continuing Operations After Tax
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Net Income/Loss
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
62.54
62.48 -62.14 62.41 62.20
Diluted Average Shares
0.10%
62.54
62.48 -63.63 62.41 63.59
Basic Earnings Per Share
0.00%
-0.28
-0.28 -0.27 -0.35 0.89
Diluted Earnings Per Share
0.00%
-0.28
-0.28 -0.27 -0.35 0.87
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.99%
$83.98
price down icon 0.97%
$26.98
price up icon 2.82%
$104.80
price down icon 0.30%
$132.17
price up icon 2.82%
biotechnology ONC
$308.91
price down icon 0.04%
Capitalizzazione:     |  Volume (24 ore):